Alerting stem cells to hurry up and heal – Science Daily
Science Daily |
Alerting stem cells to hurry up and heal
Science Daily This recent study builds upon Rodgers’ previous finding: when one part of the body suffers an injury, adult stem cells in uninjured areas throughout the body enter a primed or “Alert” state. Alert stem cells have an enhanced potential to repair tissue … Protein primes mouse stem cells to quickly repair injuryStanford Medical Center Report Speeding healing with a dose of a single proteinScope (blog) |
Chemical & Engineering News (subscription) |
CRISPR pioneer Jennifer Doudna shares her outlook for the groundbreaking gene-editing tool
Chemical & Engineering News (subscription) Inspiration for cracking the CRISPR code: My dad was not a scientist, but he loved solving puzzles. One of his favorites was cryptoquotes—quotes by famous people that are encrypted. The challenge is to break the code and solve the quote. They would … |
Harvard Gazette |
Researchers study secrets of aging via stem cells
Harvard Gazette If stem cells offer potential solutions, they’re also part of the problem. Stem cells, which can differentiate into many cell types, are important parts of the body’s repair system, but lose regenerative potency as we age. In addition, their self … New cocktail encourages stem cell diversificationLab News Delving into Stem Cell Research and its Potential 2017 – Research and MarketsYahoo Finance Plasticell to produce red blood cell substitute from pluripotent stem cellsDrug Target Review Medgadget (blog) –WhaTech all 9 news articles » |
Controlled Environments Magazine |
Nanoparticles Reprogram Immune Cells to Battle Cancer
Controlled Environments Magazine Researchers have developed strategies to rewire T cells’ genetics so that certain cancer cells pop up on their radar as dangerous. One class of engineered T cells is known as CAR T cells, for the researcher-designed chimeric antigen receptors encoded … |
|
Immunotherapy for GU Ca: A primer for urologists
ModernMedicine Immunotherapy for genitourinary malignancies is not new, as high-dose interleukin-2 (IL-2 [Proleukin]) for metastatic renal cell carcinoma (mRCC) and intravesical bacillus Calmette-Guérin for high-grade bladder cancer have been used since the 1990s. |
|
Immunotherapy for GU Ca: A primer for urologists
ModernMedicine Immunotherapy for genitourinary malignancies is not new, as high-dose interleukin-2 (IL-2 [Proleukin]) for metastatic renal cell carcinoma (mRCC) and intravesical bacillus Calmette-Guérin for high-grade bladder cancer have been used since the 1990s. |